Press Release

ZEISS Becomes Part of the Collaborative Community on Ophthalmic Innovation

Championing improved vision and lifelong visual health

12 December 2025

Aalen, Germany | 12 December 2025 | ZEISS Vision Care

ZEISS Vision Care is excited to announce its participation in the Collaborative Community of Ophthalmic Innovation (CCOI). This global initiative is dedicated to uniting diverse stakeholders to transform groundbreaking scientific discoveries into practical solutions for eye care. The collaboration reflects ZEISS Vision Care's unwavering commitment to advancing ophthalmic science and aligns with the company’s mission to protect and improve the vision and lifetime visual health of the world's consumers.

Padmaja Sankaridurg, Head of Myopia Innovation at ZEISS Vision Care: "Being part of the CCOI is an important step for ZEISS. Collaboration is key to driving innovation. By joining forces with other leaders in the field, including industry, regulatory bodies and academia, we aim to identify challenges and obstacles to ophthalmic innovation and use the collective power to enable and deliver cutting-edge solutions faster. Our involvement in the CCOI underscores our dedication to improving lives through pioneering ophthalmic and optical solutions."

Owned by a foundation, ZEISS is uniquely positioned to prioritize long-term advancements in eye and vision care over short-term results. The deep-rooted commitment to innovation is further enhanced by combining the forces of ZEISS Vision Care and ZEISS Medical Technology, which provides both companies unparalleled expertise in understanding the complete needs and complexities of the human eye and vision. This synergy allows ZEISS to leverage decades of industry leadership, cutting-edge research and digital-driven technology to address the evolving needs of consumers, patients, and vision care and healthcare practioners. Joining the CCOI reflects ZEISS’s long-standing commitment to tackle the most pressing global challenges in vision and eye care.

Press Contact Maria Conrad General Topics and Sustainability

ZEISS Vision Care

About ZEISS

ZEISS is an internationally leading technology company in the optics and optoelectronics industry. The ZEISS Group generated annual revenue totaling around 11 billion euros in its four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology (updated: 30 September 2024).

For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for life sciences and materials research, as well as medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Industry 4.0 as well as a strong brand, ZEISS is shaping technological progress and, through its solutions, is extending the horizon of the world of optics and associated areas. ZEISS' significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 14% of its revenue in research and development work – ZEISS has a long tradition of high expenditure in these areas. This also represents the company's investment in the future.

With more than 46,500 employees, ZEISS operates in around 50 countries with more than 60 sales and service sites, 40 research and development sites and 35 production sites worldwide (as of 31 March 2025). The headquarters of the company, which was founded in Jena in 1846, is located in Oberkochen, Germany. The Carl Zeiss Foundation, one of Germany’s largest foundations committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com

ZEISS Vision Care
ZEISS Vision Care is one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments. The unit is allocated to the Consumer Markets segment and develops and produces offerings for the entire eyeglass value chain that are distributed globally under the ZEISS brand.

ZEISS Medical Technology
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September).

Download

Press Release ZEISS joins CCOI

Championing Improved Vision and Lifelong Visual Health: ZEISS Becomes Part of the Collaborative Community on Ophthalmic Innovation

91 KB

Download